Systemic Lupus Erythematosus: Perinatal Outcomes in Patients Treated With and Without Hydroxychloroquine

REFERENCES

1. 1.↵
   1. Ruiz-Irastorza G,
   2. Khamashta MA

   . Lupus and pregnancy: ten questions and some answers. Lupus. 2008;17:416-420. doi: 10.1177/0961203308090027.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Clowse ME

   . Lupus activity in pregnancy. Rheum Dis Clin North Am. 2007 May;33(2):237-252, v. doi: 10.1016/j.rdc.2007.01.002.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Yasmeen S,
   2. Wilkins EE,
   3. Field NT,
   4. Sheikh RA,
   5. Gilbert WM

   . Pregnancy outcomes in women with systemic lupus erythematosus. J Matern Fetal Med. 2001 Apr;10(2):91-96. doi: 10.1080/714904302.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Levy RA,
   2. Vilela VS,
   3. Cataldo MJ,
   4. et al.

   Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus. 2001;10(6):401-404. doi: 10.1191/096120301678646137.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Parke AL

   . Antimalarial drugs, systemic lupus erythematosus and pregnancy. J Rheum. 1988 Apr;15(4):607-610.

   OpenUrlPubMedWeb of Science
6. 6.
   1. Parke A

   . Antimalarial drugs and pregnancy. Am J Med. 1988 Oct 14;85(4A):30-33. doi: 10.1016/0002-9343(88)90359-2.

   OpenUrlCrossRefPubMed
7. 7.
   1. Parke A,
   2. West B

   . Hydroxychloroquine in pregnant patients with systemic lupus erythematosus. J Rheumatol. 1996 Oct;23(10):1715-1718.

   OpenUrlPubMedWeb of Science
8. 8.↵
   1. Motta M,
   2. Tincani A,
   3. Faden D,
   4. Zinzini E,
   5. Chirico G

   . Antimalarial agents in pregnancy. Lancet. 2002 Feb 9;359(9305):524-525. doi: 10.1016/S0140-6736(02)07643-2.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Buchanan NM,
   2. Toubi E,
   3. Khamashata MA,
   4. Lima F,
   5. Kerslake S,
   6. Hughes GR

   . Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases. Ann Rheum Dis. 1996 Jul;55(7):486-488. doi: 10.1136/ard.55.7.486.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Andreoli L,
    2. Bertsias G,
    3. Agmon-Levin N,
    4. et al.

    EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy, and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis. 2017 Mar;76(3):476-485.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Flint J,
    2. Panchal S,
    3. Hurrell A,
    4. et al.

    BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford). 2016 Sep;55(9):1693-1697. doi: 10.1093/rheumatology/kev404.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Dav-Citrin O,
    2. Blyakhman S,
    3. Shechtman S,
    4. Ornoy A

    . Pregnancy outcome following in utero exposure to hydroxychloroquine: a prospective comparative observational study. Reprod Toxicol. 2013 Aug;39:58-62. doi: 10.1016/j.reprotox.2013.04.005.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Sperber K,
    2. Hom C,
    3. Chao CP,
    4. Shapiro D,
    5. Ash J

    . Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases. Pediatr Rheumatol Online J. 2009 May 13;7:9. doi: 10.1186/1546-0096-7-9.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Leroux M,
    2. Desveaux C,
    3. Parcevaux M,
    4. et al.

    Impact of hydroxychloroquine on preterm delivery and intrauterine growth restriction in pregnant women with systemic lupus erythematosus: a descriptive cohort study. Lupus. 2015 Nov;24(13):1384-1391. doi: 10.1177/0961203315591027.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Moroni G,
    2. Doria A,
    3. Giglio E

    . Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century: a prospective multicenter study. J Autoimmun. 2016 Nov;74:6-12. doi: 10.1016/j.jaut.2016.07.010.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Clowse ME,
    2. Magder L,
    3. Witter F,
    4. Petri M

    . Hydroxychloroquine in lupus pregnancy. Arthritis Rheum. 2006 Nov;54(11):3640-3647. doi: 10.1002/art.22159.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Costedoat-Chalumeau N,
    2. Amoura Z,
    3. Duhaut P,
    4. et al.

    Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum. 2003 Nov;48(11):3207-3211. doi: 10.1002/art.11304.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Peart E,
    2. Clowse ME

    . Systemic lupus erythematosus and pregnancy outcomes: an update and review of the literature. Curr Opin Rheumatol. 2014 Mar;26(2):118-123. doi: 10.1097/BOR.0000000000000030.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Izmirly P,
    2. Kim MY,
    3. Llanos C,
    4. et al.

    Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine. Ann Rheum Dis. 2010 Oct;69(10):1827-1830. doi: 10.1136/ard.2009.119263.

    OpenUrlAbstract/FREE Full Text